Vistra [VST] vs TransAlta [TAC] Detailed Stock Comparison
Vistra
NYSE
Loading...
TransAlta
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vistra wins in 10 metrics, TransAlta wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Vistra | TransAlta | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 32.44 | 1,227.00 | Vistra |
| Price-to-Book Ratio | 29.20 | 5.62 | TransAlta |
| Debt-to-Equity Ratio | 373.84 | 271.26 | TransAlta |
| PEG Ratio | 29.29 | 38.97 | Vistra |
| EV/EBITDA | 13.28 | 10.88 | TransAlta |
| Profit Margin (TTM) | 12.90% | -4.59% | Vistra |
| Operating Margin (TTM) | 13.72% | 20.00% | TransAlta |
| EBITDA Margin (TTM) | 13.72% | 20.00% | TransAlta |
| Return on Equity | 39.30% | -7.23% | Vistra |
| Return on Assets (TTM) | 5.87% | 1.56% | Vistra |
| Free Cash Flow (TTM) | $2.49B | $475.00M | Vistra |
| Dividend Yield | 0.24% | 0.70% | TransAlta |
| 1-Year Return | 157.02% | 50.06% | Vistra |
| Price-to-Sales Ratio (TTM) | 3.71 | 1.43 | TransAlta |
| Enterprise Value | $88.60B | $6.47B | Vistra |
| EV/Revenue Ratio | 4.79 | 3.55 | TransAlta |
| Gross Profit Margin (TTM) | 20.16% | 77.14% | TransAlta |
| Revenue per Share (TTM) | $54 | $8 | Vistra |
| Earnings per Share (Diluted) | $6.23 | $-0.39 | Vistra |
| Beta (Stock Volatility) | 1.31 | 0.55 | TransAlta |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vistra vs TransAlta Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vistra | -1.69% | -2.85% | 6.28% | 43.44% | 20.03% | 35.05% |
| TransAlta | 0.50% | -2.34% | 15.93% | 41.95% | 12.37% | -14.20% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vistra | 157.02% | 680.99% | 961.00% | 1,171.19% | 1,171.19% | 1,171.19% |
| TransAlta | 50.06% | 21.41% | 89.34% | 122.47% | -38.46% | -34.31% |
Performance & Financial Health Analysis: Vistra vs TransAlta
| Metric | VST | TAC |
|---|---|---|
| Market Information | ||
| Market Cap | $68.59B | $3.59B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 5,394,470 | 1,229,020 |
| 90 Day Avg. Volume | 5,250,543 | 1,100,273 |
| Last Close | $202.12 | $12.08 |
| 52 Week Range | $72.90 - $216.85 | $7.82 - $14.64 |
| % from 52W High | -6.79% | -17.49% |
| All-Time High | $216.85 (Aug 05, 2025) | $37.84 (Jul 21, 2008) |
| % from All-Time High | -6.79% | -68.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | -0.26% |
| Quarterly Earnings Growth | -0.10% | -0.26% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | -0.05% |
| Operating Margin (TTM) | 0.14% | 0.20% |
| Return on Equity (TTM) | 0.39% | -0.07% |
| Debt to Equity (MRQ) | 373.84 | 271.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.92 | $2.15 |
| Cash per Share (MRQ) | $1.43 | $0.75 |
| Operating Cash Flow (TTM) | $4.23B | $441.96M |
| Levered Free Cash Flow (TTM) | $1.74B | $143.75M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.24% | 0.70% |
| Last 12-Month Dividend | $0.44 | $0.08 |
Valuation & Enterprise Metrics Analysis: Vistra vs TransAlta
| Metric | VST | TAC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 32.44 | 1,227.00 |
| Forward P/E | 29.29 | 38.97 |
| PEG Ratio | 29.29 | 38.97 |
| Price to Sales (TTM) | 3.71 | 1.43 |
| Price to Book (MRQ) | 29.20 | 5.62 |
| Market Capitalization | ||
| Market Capitalization | $68.59B | $3.59B |
| Enterprise Value | $88.60B | $6.47B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.79 | 3.55 |
| Enterprise to EBITDA | 13.28 | 10.88 |
| Risk & Other Metrics | ||
| Beta | 1.31 | 0.55 |
| Book Value per Share (MRQ) | $6.92 | $2.15 |
Financial Statements Comparison: Vistra vs TransAlta
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VST | TAC |
|---|---|---|
| Revenue/Sales | $3.93B | $758.00M |
| Cost of Goods Sold | $3.14B | $326.00M |
| Gross Profit | $793.00M | $432.00M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-120.00M | $100.00M |
| EBITDA | $619.00M | $250.00M |
| Pre-Tax Income | $-444.00M | $49.00M |
| Income Tax | $-176.00M | $7.00M |
| Net Income (Profit) | $-268.00M | $42.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VST | TAC |
|---|---|---|
| Cash & Equivalents | $561.00M | $238.00M |
| Total Current Assets | $8.43B | $1.76B |
| Total Current Liabilities | $9.75B | $2.09B |
| Long-Term Debt | $15.72B | $3.70B |
| Total Shareholders Equity | $4.84B | $1.83B |
| Retained Earnings | $-835.00M | $-2.43B |
| Property, Plant & Equipment | $2.99B | $6.04B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VST | TAC |
|---|---|---|
| Operating Cash Flow | $160.00M | $153.00M |
| Capital Expenditures | $0 | $-32.00M |
| Free Cash Flow | $-169.00M | $-27.00M |
| Debt Repayment | $-6.00M | $-374.00M |
| Common Stock Repurchase | $-337.00M | $-3.00M |
Short Interest & Institutional Ownership Analysis
| Metric | VST | TAC |
|---|---|---|
| Shares Short | 8.21M | 8.83M |
| Short Ratio | 1.68 | 7.31 |
| Short % of Float | 0.03% | 0.03% |
| Average Daily Volume (10 Day) | 5,394,470 | 1,229,020 |
| Average Daily Volume (90 Day) | 5,250,543 | 1,100,273 |
| Shares Outstanding | 339.75M | 297.50M |
| Float Shares | 316.65M | 261.66M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 0.88% | 0.79% |
Dividend Analysis & Yield Comparison: Vistra vs TransAlta
| Metric | VST | TAC |
|---|---|---|
| Last 12-Month Dividend | $0.44 | $0.08 |
| Last 12-Month Dividend Yield | 0.24% | 0.70% |
| 3-Year Avg Annual Dividend | $0.75 | $0.13 |
| 3-Year Avg Dividend Yield | 0.55% | 0.47% |
| 3-Year Total Dividends | $2.24 | $0.40 |
| Ex-Dividend Date | Dec 20, 2024 | Nov 29, 2024 |